Return to content in this issue

 

Usefulness of Omalizumab in Rapid Drug Desensitization in Patients with Severe Anaphylaxis Induced by Carboplatin: Open Questions

Sánchez-Morillas L1, Casado Herráez A2, Rubio-Perez M3, Robledo Echarren T4, González Gutiérrez ML4, Cimarra M4, Vázquez Cortés S1, Cerecedo I1, Fernández-Rivas M5

1Allergology Department. Hospital Clínico San Carlos, IdISSC, ARADyAL RD16/0006/0009. Madrid. Spain.
2Medical Oncology Department. Hospital Clínico San Carlos, UCM, IdISSC. Madrid. Spain.
3Allergology Department. Hospital InfantaSofía. Madrid. Spain.
4Allergology Department. Hospital Clínico San Carlos, IdISSC. Madrid. Spain.
5Allergology Department. Hospital Clínico San Carlos, IdISSC, UCM, ARADyAL RD16/0006/0009. Madrid. Spain.

J Investig Allergol Clin Immunol 2020; Vol. 30(4)
doi: 10.18176/jiaci.0499

Key words: Chemotherapeutic Drugs, Carboplatin, Omalizumab, Rapid drug desensitization